Acalabrutinib N2-Oxide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Acalabrutinib N2-Oxide

● In Stock

Catalogue No.:VE0023230
CAS No.:N/A
Mol. Formula:C26H23N7O3
Mol. Weight:481.51 g/mol

Additional information on Acalabrutinib N2-Oxide

Parent drug

Acalabrutinib

IUPAC Name

(S)-2-(4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)benzamido)pyridine 1-oxide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

[O-][N+]1=CC=CC=C1NC(C2=CC=C(C3=C(C(N)=NC=C4)N4C([C@@H]5CCCN5C(C#CC)=O)=N3)C=C2)=O

InChI

InChI=1S/C26H23N7O3/c1-2-6-21(34)31-14-5-7-19(31)25-30-22(23-24(27)28-13-16-32(23)25)17-9-11-18(12-10-17)26(35)29-20-8-3-4-15-33(20)36/h3-4, 8-13, 15-16, 19H, 5, 7, 14H2, 1H3, (H2, 27, 28)(H, 29, 35)/t19-/m0/s1

Description

The Acalabrutinib N2-Oxide standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Acalabrutinib. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes. To further support research and development | it comes with a comprehensive Structure Elucidation Report (SER) | providing detailed insights for advanced analysis.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url